BLUEJAY THERAPEUTICS
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases. The company’s first target indication is chronic Hepatitis B, which remains a worldwide prevalent disease with urgent unmet medical need. Bluejay is advancing two innovative approaches with the potential for high rate of functional cure: best-in-class fully human IgG1 anti-HBs monoclonal antibodies and first-in-class HBsAg oral small molecule inhibitors. The company believes that by reducing hepatitis B surface antigen and restoring adaptive immunity a functional cure could be achieved for patients.
BLUEJAY THERAPEUTICS
Industry:
Biotechnology Health Care
Website Url:
http://www.bluejaytx.com
Status:
Active
Total Funding:
41 M USD
Similar Organizations
Barr Pharmaceuticals
Barr Pharmaceuticals was a global specialty pharmaceutical company that operated in more than 30 countries worldwide.
Elusys Therapeutics
Elusys Therapeutics is a private company focused on the development of antibody therapeutics for the treatment of infectious disease.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Oraxion Therapeutics
Oraxion Therapeutics is a drug discovery company focused on rare and orphan diseases.
Sanomune
Sanomune is a product based biopharmaceutical company oriented towards therapeutic regulation of the immune system.
Telesta Therapeutics
Telesta Therapeutics is a biopharmaceutical company focused on the licensing, acquisition, and development of transformational therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
Synergenics
Synergenics investment in Series B - Bluejay Therapeutics
Octagon Capital Advisors
Octagon Capital Advisors investment in Series B - Bluejay Therapeutics
Arkin Bio Ventures
Arkin Bio Ventures investment in Series B - Bluejay Therapeutics
RiverVest
RiverVest investment in Series B - Bluejay Therapeutics
Yonjin Venture
Yonjin Venture investment in Series B - Bluejay Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-02 | Bluejay Therapeutics Announces the Appointment of Nancy Shulman, M.D., as Chief Medical Officer |
Official Site Inspections
http://www.bluejaytx.com Semrush global rank: 5.77 M Semrush visits lastest month: 1.45 K
- Host name: 60.91.138.34.bc.googleusercontent.com
- IP address: 34.138.91.60
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Bluejay Therapeutics"
About Bluejay Therapeutics - Bluejay Therapeutics
It's personalBluejay is on a mission to illuminate a path toward curative treatments for serious viral and liver diseases.At Bluejay, we are discovering life-changing medicines and cures for people …See details»
Bluejay Therapeutics Announces Expansion of Leadership Team …
Nov 21, 2024 “We are building our organization to accelerate the development of BJT-778 and meet the goal of improving patients’ lives.” ... (HBV) transcript inhibitor (BJT-628). For more …See details»
Bluejay Therapeutics - Crunchbase Company Profile
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases. The company’s first target indication is chronic Hepatitis B, which remains a worldwide prevalent disease …See details»
Bluejay Therapeutics Announces Expansion of Leadership Team
Nov 21, 2024 “We are building our organization to accelerate the development of BJT-778 and meet the goal of improving patients’ lives.” The new additions to the Bluejay Therapeutics …See details»
Bluejay Therapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Bluejay Therapeutics, Inc. of South San Francisco, CA. Get the latest business insights from Dun & …See details»
Bluejay Therapeutics Announces Expansion of Leadership Team …
Nov 21, 2024 “We are building our organization to accelerate the development of BJT-778 and meet the goal of improving patients’ lives.” The new additions to the Bluejay Therapeutics …See details»
Bluejay Therapeutics Company Profile | Management and
Www.bluejaytx.com . Bluejay Therapeutics Profile and History. Based in San Francisco, California, Bluejay Therapeutics is a novel therapeutic development company. Popular Searches. Bluejay …See details»
2024 - Bluejay Therapeutics
“We are building our organization to accelerate the development of BJT-778 and meet the goal of improving patients’ lives.” ... transcript inhibitor (BJT-628). For more information on Bluejay, …See details»
Bluejay Therapeutics Company Profile 2024: Valuation, …
Www.bluejaytx.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 951 Mariners Island Boulevard; Suite 300; San Mateo, CA 94404; United StatesSee details»
Bluejay Therapeutics - Company Profile - Tracxn
Dec 2, 2024 Bluejay Therapeutics - Developer of therapeutics for the treatment of infectious diseases. Raised a total funding of $243M over 3 rounds from 13 investors. Founded by …See details»
Bluejay Therapeutics Company Overview, Contact Details
May 9, 2024 Bluejay Therapeutics Inc. is developing cavrotolimod for potential treatment for hepatitis on Feb 5th '24. Exicure, Inc., (NASDAQ:XCUR) a company that historically …See details»
Bluejay Therapeutics expands management team and hired
Sep 21, 2023 Bluejay Therapeutics is a clinical stage private biopharmaceutical company committed to developing effective treatments and cures for viral and liver diseases …See details»
News - Bluejay Therapeutics
Oct 16, 2024 [email protected]. Keting Chu Founder, Chief Executive Officer and Chairman of the Board. Dr. Keting Chu is an experienced biotech executive, entrepreneur and life science …See details»
Bluejay Therapeutics Announces Expansion of Leadership Team
Nov 21, 2024 “We are building our organization to accelerate the development of BJT-778 and meet the goal of improving patients’ lives.” ... For more information on Bluejay, please visit the …See details»
Bluejay Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
For more information on Bluejay, please visit the company’s website at www.bluejaytx.com. Contacts Investors & Media: Argot Partners [email protected] . Orphan Drug ... The …See details»
Bluejay Therapeutics - Overview, News & Similar companies
View Bluejay Therapeutics (bluejaytx.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Bluejay Therapeutics Announces Expansion of Leadership Team …
Nov 21, 2024 "We are building our organization to accelerate the development of BJT-778 and meet the goal of improving patients' lives.” The new additions to the Bluejay Therapeutics …See details»
Bluejay Therapeutics, Inc. (Bluejay Therapeutics, Inc.) - 药物管线_专 …
100% of treated patients in Arm 1 achieved virologic response by Week 28 Most patients also achieved ALT normalization and composite response BJT-778 was well tolerated across all …See details»
Press Release - Bluejay Therapeutics
For more information on Bluejay, please visit the company’s website at www.bluejaytx.com or follow the company on LinkedIn. Bluejay Therapeutics Reports Best-in-Class Monoclonal …See details»